| Trial Identifier: | D2287R00139 |
| Sponsor: | AstraZeneca |
| NCTID:: | NCT03963141 |
| Start Date: | August 2019 |
| Primary Completion Date: | October 2022 |
| Study Completion Date: | October 2022 |
| Condition: | Asthma |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
| Country | Location |
|---|---|
| United Arab Emirates | Dubai, United Arab Emirates |